Quantum Genesis AI Corp. Responds to OTC Markets Caveat Emptor Designation

Quantum Genesis AI Corp. has issued a statement regarding the Caveat Emptor designation placed on the company’s securities by OTC Markets Group, Inc. on February 12, 2026. The designation, which indicates potential risks for investors, was applied due to what OTC Markets described as a ‘public interest concern.’ Since the designation, the company has made several attempts to communicate with OTC Markets to better understand the basis for the designation and determine necessary steps to address it.

The company has requested additional clarification and intends to continue cooperating with OTC Markets. OTC Markets recently informed Quantum Genesis AI that it may formally request a review of the Caveat Emptor designation beginning March 13, 2026. The company plans to engage with OTC Markets at the earliest available opportunity to initiate that review process. For more information, investors can visit the company’s website at https://www.qgaicorp.com and its profile at https://www.otcmarkets.com/stock/QGAI.

Naveen Kulkarni, Chief Executive Officer of Quantum Genesis AI Corp., stated that the company takes the matter seriously and is committed to working constructively with OTC Markets. ‘Our objective is to obtain clarity regarding the matter and to take any appropriate steps necessary as we move through the review process,’ Kulkarni said. The company remains committed to maintaining transparency with its shareholders and the broader investment community and intends to provide updates as additional information becomes available.

The Caveat Emptor designation highlights regulatory scrutiny that can affect investor confidence and market perception. For companies trading on OTC markets, such designations can impact stock liquidity and valuation, making resolution through formal review processes critical. Quantum Genesis AI’s response underscores the importance of corporate transparency and regulatory compliance in maintaining market integrity. The outcome of the review process could have implications for the company’s ability to attract investment and operate in regulated financial markets.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Quantum Genesis AI Corp. Responds to OTC Markets Caveat Emptor Designation.

The post Quantum Genesis AI Corp. Responds to OTC Markets Caveat Emptor Designation appeared first on citybuzz.